Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
CN¥15.80 - CN¥39.02
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | CN¥15.63B |
EV | CN¥14.25B |
Shares Outstanding | 404.59M |
Beta | - |
Analyst Rating | BUY |
Analyst Target Price | CN¥35.42 |
P/E 2025E | 39.10x |
P/Revenue 2025E | 9.06x |
Revenue | 31.30% |
EPS | 27.20% |
Operating Cash Flow | 22.90% |
Free Cash Flow | - |
Revenue | 29.60% |
EPS | 27.70% |
Operating Cash Flow | 32.80% |
Free Cash Flow | - |
Gross Margin 2025E | 58.59% |
Net Profit Margin 2025E | 23.27% |
ROE 2025E | 17.74% |
ROCE 2024 | 15.00% |
DPS 2025E | CN¥0.23 |
Payout Ratio 2025E | 23.23% |
Div. Yield 2025E | 0.60% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Runben Biotechnology Co., Ltd.
603193
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Data Unavailable
Employees
921
Website
www.runben.comIPO Date
Headquarters
No. 3, Xinzhuang 5th Road, Guangzhou Economic and Technological Development Zone, Guangzhou, Guangdong Province, 510627, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved